Evidence map›Paper›PMID 32923135›Full record

ArticleOncoimmunology2020

Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.

Maria-Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa, Michael Friedrich, Diana Handke, Anja Mueller, Simon Jasinski-Bergner, Reinhard Dummer, Peter Koelblinger, Barbara Seliger

Open access · goldAbstract read
In one paragraph

Article in Oncoimmunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy.International journal of molecular sciences · 2022
    Pooled it
  2. Review
  3. Omics in Cutaneous Melanoma.Asian Pacific journal of cancer prevention : APJCP · 2025
    Review
  4. Review
  5. Review
  6. Review
  7. Topology and Dynamics of Transcriptome (Dys)Regulation.International journal of molecular sciences · 2024
    Article
  8. Bridging the divide: unveiling mutual immunological pathways of cancer and pregnancy.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. MicroRNAs affecting the susceptibility of melanoma cells to CD8Clinical and translational medicine · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 4 countries.

Maria-Filothei LazaridouInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Evamaria GonschorekInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Chiara MassaInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Michael FriedrichInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Diana HandkeInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Anja MuellerInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Simon Jasinski-BergnerInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Reinhard DummerInstitute of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Peter KoelblingerDepartment of Dermatology and Allergology, University Hospital Salzburg, Salzburg, Austria.
Barbara SeligerInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.ORCID 0000-0002-5544-4958
Luther University · KRUnfallkrankenhaus Salzburg · ATUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor escape is often associated with abnormalities in the surface expression of the human leukocyte antigen class I (HLA-I) antigens thereby limiting CD8 Abbreviations: Ab: antibody; ACTB: β-actin; APM: antigen processing and presentation machinery; ATCC: American tissue culture collection; β

Indexed as

MelanomaMicroRNAsAntigen PresentationATP Binding Cassette Transporter, Subfamily B, Member 2HEK293 CellsHumansLeukocytes, MononuclearPeptide Transporter 1ATP Binding Cassette Transporter, Subfamily B, Member 2MicroRNAsPeptide Transporter 1TAP1 protein, humanHLAimmune escapemicroRNAPeptide transportertumor

Identifiers

PMID32923135
PMCPMC7458634
OpenAlexW3033929728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.